Aspen Pharmacare chair Kuseni Dlamini will step down from the pharmaceutical group’s board in December 2026. Veteran director and former banking executive Ben Kruger will succeed him as chair. Aspen said Dlamini would not make himself available for re-election as a director. The company’s annual general meeting is scheduled for December. His departure will conclude a 14-year tenure on the…
Tag: Weight-Loss Medicines
-
iDexis Semaglutide Ban Ordered By High Court
The High Court has temporarily stopped pharmacy group iDexis from manufacturing, supplying and marketing weight-loss medicines containing semaglutide. The iDexis semaglutide ban follows an application by Danish pharmaceutical company Novo Nordisk. The company manufactures Ozempic and Wegovy. Semaglutide is the active ingredient in both medicines. Ozempic is registered as a treatment for diabetes. Wegovy is approved for weight management. The…